Generated by GPT-5-mini| Escherichia coli K-12 | |
|---|---|
| Name | Escherichia coli K-12 |
| Domain | Bacteria |
| Phylum | Proteobacteria |
| Classis | Gammaproteobacteria |
| Ordo | Enterobacterales |
| Familia | Enterobacteriaceae |
| Genus | Escherichia |
| Species | coli |
| Binomial | Escherichia coli K-12 |
Escherichia coli K-12 is a nonpathogenic laboratory strain of a bacterial species long used in molecular biology, genetics, and biotechnology, with roots in early 20th-century microbial research and adoption by major research institutions and biotechnology firms. It serves as a standard model organism in studies linked to foundational figures and institutions in microbiology, genetics, and molecular biology, underpinning technologies developed at places such as Cold Spring Harbor Laboratory, Max Planck Society, and biotech companies like Genentech and Amgen. Widely sequenced and curated by consortia and genome projects associated with institutions including the Wellcome Sanger Institute, National Institutes of Health, and European Molecular Biology Laboratory, the strain remains a cornerstone for experimental methods elaborated by scientists connected to the Nobel Prizes, Royal Society, and academic publishers.
K-12 traces to isolates collected in the early 1900s amid work by researchers in bacteriology connected to institutions such as the Pasteur Institute, Johns Hopkins University, and University of Cambridge, and it entered laboratory use through stewardship at places like Rockefeller University and University of Pennsylvania. The strain became prominent after methods developed by scientists associated with the Max Planck Society, Cold Spring Harbor Laboratory, and Cambridge University Press disseminated protocols, while subsequent standardization was influenced by collections such as the American Type Culture Collection and culture repositories tied to the National Center for Biotechnology Information. Historical lines of E. coli used in laboratories were shaped by collaborations involving figures linked to the Nobel Prize, Royal Society, and institutes such as the Institut Pasteur and Karolinska Institutet.
Genomic characterization of K-12 was advanced through projects undertaken by the Wellcome Sanger Institute, National Institutes of Health, and European Molecular Biology Laboratory, and multiple derivatives such as MG1655, DH5α, and W3110 were generated in laboratories affiliated with institutions like MIT, Harvard University, and Stanford University. Genetic tools and plasmids propagated in K-12 backgrounds were developed by researchers connected to institutions including the Howard Hughes Medical Institute, California Institute of Technology, and University of California, Berkeley, and these tools interact with mobile elements first described by investigators at institutions such as Columbia University and Yale University. Comparative genomics involving K-12 and pathogenic strains have been reported by teams at the Pasteur Institute, Wellcome Trust, and Institut Pasteur, informing annotation efforts coordinated with databases maintained by the European Bioinformatics Institute and National Center for Biotechnology Information.
K-12 underpins routine cloning, expression, and synthetic biology workflows employed in laboratories at biotechnology companies such as Genentech, Amgen, and Biogen and in academic centers including MIT, Harvard, and University of Oxford, and it is central to educational exercises delivered by institutions like Stanford University and University of Cambridge. The strain has been used as a chassis for metabolic engineering projects reported by groups at ETH Zurich, Technical University of Munich, and Max Planck Institute for Molecular Genetics, and as a platform for CRISPR technologies developed at the Broad Institute, University of California, Berkeley, and University of California, San Francisco. Industrial applications and scale-up practices have been informed by collaborations with firms and institutions such as DuPont, Bayer, and the National Institute of Standards and Technology, and commercial kits and reagents supporting K-12 work are produced by companies including Thermo Fisher Scientific, New England Biolabs, and Qiagen.
K-12 exhibits growth parameters and metabolic behaviors characterized in studies conducted at laboratories affiliated with institutions such as Massachusetts Institute of Technology, University of California, Davis, and Wageningen University, with physiological traits measured by researchers connected to the European Molecular Biology Laboratory, Max Planck Society, and RIKEN. Its aerobic and anaerobic metabolism, nutrient uptake, and response to stressors have been probed using methods developed at places like the Scripps Research Institute, Johns Hopkins University, and Imperial College London, with data integrated into models maintained by groups at ETH Zurich, Carnegie Institution for Science, and Lawrence Berkeley National Laboratory. Standard culture conditions and media formulations for K-12 are those standardized by repositories and procedural guides from the American Society for Microbiology, Cold Spring Harbor Laboratory, and the Federation of European Microbiological Societies.
K-12 is designated as nonpathogenic and is classified at biosafety level 1 by regulatory frameworks overseen by agencies including the Centers for Disease Control and Prevention, European Centre for Disease Prevention and Control, and World Health Organization, and institutional biosafety committees at universities such as Harvard, Yale, and University of California implement containment guidance referencing these agencies. Strain handling, disposal, and recombinant DNA work involving K-12 follow policies influenced by laws and guidelines from bodies like the National Institutes of Health, Office of Biotechnology Activities, and Cartagena Protocol signatories, and compliance is overseen by institutional review boards and bioethics committees at organizations such as the Rockefeller University and Pasteur Institute. International shipment, accessioning, and cataloging of K-12 derivatives are managed by culture collections and standards organizations including the American Type Culture Collection, DSMZ, and International Organization for Standardization.